세계의 기관지경하 생검 기기 시장 : 제품 유형별, 수기 유형별, 용도별, 최종 사용자별 - 예측(2025-2030년)

The Bronchoscopic Biopsy Devices Market was valued at USD 712.09 million in 2023, expected to reach USD 764.65 million in 2024, and is projected to grow at a CAGR of 7.72%, to USD 1,198.63 million by 2030.

As a market research analyst focusing on bronchoscopic biopsy devices, it's essential to understand the scope and definition of this market segment. These devices are primarily used to obtain tissue samples from the lungs during a bronchoscopy, crucial for diagnosing conditions like lung cancer and other pulmonary diseases. Their necessity arises from the increasing prevalence of respiratory diseases and advancements in diagnostic technologies, which have paved the way for enhanced procedural accuracy. The devices serve healthcare providers and medical research, enabling early disease detection and personalized treatment planning, which is vital in improving patient outcomes. Key growth factors include rising awareness of lung health, increased healthcare expenditure, and ongoing technological innovations that make procedures less invasive and more effective. Additionally, the aging population worldwide contributes to market demand, given their vulnerability to lung diseases. Opportunities emerge from the untapped potential in emerging economies, where healthcare infrastructure is rapidly developing. Companies can leverage these opportunities by focusing on cost-effective solutions and strategic partnerships with local healthcare providers. However, the market faces limitations like stringent regulatory requirements, high costs associated with advanced devices, and potential complications in certain patient segments, all of which can hinder growth. Addressing these challenges by investing in R&D, especially in AI and machine learning for improved diagnostic capabilities, could push the market forward. Areas ripe for innovation include the development of disposable bronchoscopic biopsy devices to reduce cross-contamination risks and enhance safety. Furthermore, collaboration with pulmonologists to refine device functionality based on clinical feedback can drive efficiency and acceptance. The market exhibits dynamic nature with a strong focus on technological advancements but requires strategic approaches to navigate regulatory hurdles and cost considerations effectively. Companies that successfully innovate and adapt to these changing dynamics can achieve significant growth and establish a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bronchoscopic Biopsy Devices Market

The Bronchoscopic Biopsy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of respiratory diseases globally
  • Growing preference for minimally invasive procedures
• Market Restraints
  • High cost of bronchoscopic biopsy-associated procedures
• Market Opportunities
  • Rising innovations in bronchoscopic biopsy procedures
  • Government initiatives to increase awareness of the importance of early detection and screening of lung diseases
• Market Challenges
  • Risk of complications with the usage of bronchoscopic biopsy devices

Porter's Five Forces: A Strategic Tool for Navigating the Bronchoscopic Biopsy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bronchoscopic Biopsy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bronchoscopic Biopsy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bronchoscopic Biopsy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bronchoscopic Biopsy Devices Market

A detailed market share analysis in the Bronchoscopic Biopsy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bronchoscopic Biopsy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bronchoscopic Biopsy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bronchoscopic Biopsy Devices Market

A strategic analysis of the Bronchoscopic Biopsy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bronchoscopic Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Ambu A/S, Teleflex Incorporated, CONMED Corporation, Medtronic PLC, Merit Medical Systems, Inc., FUJIFILM Holdings Corporation, Olympus Corporation, Erbe Elektromedizin GmbH, Richard Wolf GmbH, KARL STORZ SE & Co. KG, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Micro-Tech (Nanjing) Co., Ltd, Shanghai Aohua Photoelectricity Endoscope Co.,Ltd., Body Vision Medical Inc., Cook Group Incorporated, Medi-Globe GmbH, and Becton, Dickinson, and Company.

Market Segmentation & Coverage

This research report categorizes the Bronchoscopic Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Brush Biopsy Devices, Cryo Biopsy Devices, Forceps Biopsy Devices, and Needle Biopsy Devices. The Cryo Biopsy Devices is further studied across Cryo Units, Cryoprobes, and Cryospray Systems. The Forceps Biopsy Devices is further studied across Alligator Forceps, Cup Forceps, and Oval Forceps. The Needle Biopsy Devices is further studied across Core Needle Biopsy Needles and Fine Needle Aspiration Needles.
• Based on Procedure Type, market is studied across Flexible Bronchoscopy and Rigid Bronchoscopy.
• Based on Technique, market is studied across Image Guided Biopsy and Non-Image Guided Biopsy. The Image Guided Biopsy is further studied across Computed Tomography Guided Biopsy, MRI-Guided Biopsy, Stereotactic-Guided Biopsy, and Ultrasound-Guided Biopsy.
• Based on Application, market is studied across Cancer Diagnosis and Infectious Disease Diagnosis.
• Based on End-User, market is studied across Academic & Research Institutes, Diagnostic & Imaging Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of respiratory diseases globally
    • 5.1.1.2. Growing preference for minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of bronchoscopic biopsy-associated procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising innovations in bronchoscopic biopsy procedures
    • 5.1.3.2. Government initiatives to increase awareness of the importance of early detection and screening of lung diseases
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of complications with the usage of bronchoscopic biopsy devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for cryo biopsy devices in research and specialized facilities
  • 5.2.2. Procedure Type: Growing usage of flexible bronchoscopy due to their lower risk of complications and high patient tolerance
  • 5.2.3. Technique: High potential of image guided biopsy techniques to enhance the precision of biopsies
  • 5.2.4. End-user: Growing usage of bronchoscopic biopsy devices in hospitals to provide comprehensive healthcare services
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bronchoscopic Biopsy Devices Market, by Product

• 6.1. Introduction
• 6.2. Brush Biopsy Devices
• 6.3. Cryo Biopsy Devices
  • 6.3.1. Cryo Units
  • 6.3.2. Cryoprobes
  • 6.3.3. Cryospray Systems
• 6.4. Forceps Biopsy Devices
  • 6.4.1. Alligator Forceps
  • 6.4.2. Cup Forceps
  • 6.4.3. Oval Forceps
• 6.5. Needle Biopsy Devices
  • 6.5.1. Core Needle Biopsy Needles
  • 6.5.2. Fine Needle Aspiration Needles

7. Bronchoscopic Biopsy Devices Market, by Procedure Type

• 7.1. Introduction
• 7.2. Flexible Bronchoscopy
• 7.3. Rigid Bronchoscopy

8. Bronchoscopic Biopsy Devices Market, by Technique

• 8.1. Introduction
• 8.2. Image Guided Biopsy
  • 8.2.1. Computed Tomography Guided Biopsy
  • 8.2.2. MRI-Guided Biopsy
  • 8.2.3. Stereotactic-Guided Biopsy
  • 8.2.4. Ultrasound-Guided Biopsy
• 8.3. Non-Image Guided Biopsy

9. Bronchoscopic Biopsy Devices Market, by Application

• 9.1. Introduction
• 9.2. Cancer Diagnosis
• 9.3. Infectious Disease Diagnosis

10. Bronchoscopic Biopsy Devices Market, by End-User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Diagnostic & Imaging Centers
• 10.4. Hospitals

11. Americas Bronchoscopic Biopsy Devices Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Bronchoscopic Biopsy Devices Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Bronchoscopic Biopsy Devices Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Medtronic's VERITAS study highlights the ILLUMISITE platform as a safer, more effective alternative to CT-guided biopsies, paving the way for advanced bronchoscopic procedures
  • 14.3.2. Cook Medical unveils EchoTip AcuCore biopsy needle advancements in manufacturing drive precision and efficiency
  • 14.3.3. Body Vision Medical announces exclusive partnership with HugeMed to enhance and expand cost-effective bronchoscopic biopsy solutions globally
  • 14.3.4. AI-Powered LungVision and FUJIFILM integration revolutionizes bronchoscopic biopsy with real-time CT scanning, enhancing early lung cancer detection and patient outcomes
  • 14.3.5. Body Vision Medical and HugeMed Forge partnership to advance bronchoscopic biopsy technology, aiming for improved diagnostic accuracy and patient outcomes
  • 14.3.6. Praxis Medical Secures FDA 510(k) clearance for revolutionary EndoCore EBUS-TBNA biopsy device, aiming to transform lung cancer diagnostics
  • 14.3.7. Broncus Medical unveils advanced transbronchial needle to enhance lung biopsy precision and safety
  • 14.3.8. BIOSTAR unveiled advanced cTBNA and EBUS-TBNA needles to help lung cancer diagnostics with enhanced precision, patient comfort, and market penetration
  • 14.3.9. Noah Medical Secures USD 150 million series B funding to propel robotic lung biopsy innovation and market expansion
  • 14.3.10. Noah Medical secures FDA clearance for Galaxy System, revolutionizing bronchoscopic procedures with advanced real-time imaging
• 14.4. Strategy Analysis & Recommendation
  • 14.4.1. Boston Scientific Corporation
  • 14.4.2. Medtronic PLC
  • 14.4.3. Olympus Corporation
  • 14.4.4. KARL STORZ SE & Co. KG

Companies Mentioned

• 1. Ambu A/S
• 2. Teleflex Incorporated
• 3. CONMED Corporation
• 4. Medtronic PLC
• 5. Merit Medical Systems, Inc.
• 6. FUJIFILM Holdings Corporation
• 7. Olympus Corporation
• 8. Erbe Elektromedizin GmbH
• 9. Richard Wolf GmbH
• 10. KARL STORZ SE & Co. KG
• 11. Boston Scientific Corporation
• 12. Johnson & Johnson Services, Inc.
• 13. Micro-Tech (Nanjing) Co., Ltd
• 14. Shanghai Aohua Photoelectricity Endoscope Co.,Ltd.
• 15. Body Vision Medical Inc.
• 16. Cook Group Incorporated
• 17. Medi-Globe GmbH
• 18. Becton, Dickinson, and Company